Circulating tumor DNA (ctDNA) in patients with muscle-invasive bladder cancer (MIBC) who received perioperative durvalumab (D) in NIAGARA
Powles et al, ASCO 2025
Read More
Oncology
Resources related to tests that help detect circulating tumor DNA for molecular residual disease assessment.
-
-
Longitudinal ctDNA monitoring for post-surgical molecular residual disease in patients with stage I-IIIb melanoma
Ansstas et al, ASCO 2025
Read More
-
Predicting nodal burden after neoadjuvant chemotherapy (NAC) with circulating tumor (ct)DNA for surgical planning: Results from the I-SPY2 t
Mukhtar et al, ASCO 2025
Read More
-
Circulating tumor DNA (ctDNA) dynamics as a predictor of treatment response in metastatic breast cancer (mBC)
Razavi et al, ASCO 2025
Read More
-
Circulating tumor (ct)DNA monitoring of ER+/HER2- high-risk breast cancer during adjuvant endocrine therapy
Pusztai et al, ASCO 2025
Read More
-
Zaanan 2025 Nature Communications
Read More
-
Abdelrahim 2025 ctDNA and HCC
Read More
-
Nasca et al. TRINITY Study Protocol - 2025 BMC Cancer
Read More
-
Zhang et al. Pancreatic Cancer - Biomedicines 2025
Read More
-
New data from ASCO 2025 & clinical performance of Natera’s ultra-sensitive MRD platform
Watch Video
-
Comparison of surveillance circulating tumor DNA and Merkel polyomavirus antibody titer for detection of Merkel cell carcinoma recurrence
Chan et al. ASCO 2025
Read More
-
Circulating tumor DNA (ctDNA) dynamics during anti-PD-1 based therapy may predict clinical outcomes in advanced stage melanoma: a multicente
Burkey et al. ASCO 2025
Read More
-
ctDNA monitoring with Signatera: An overview for transplant providers
Watch Video
-
MRD in a minute: Marcus Noel, MD
Watch Video
-
MRD in a minute: Saum Ghodoussipour, MD
Watch Video
-
MRD in a minute: John Sfakianos, MD
Watch Video
-
MRD in a minute: Abstract overview Adanma Ayanambakkam, MD
Watch Video
-
MRD in a minute: Caroline Koffke, BSN, RN
Watch Video
-
MRD in a minute: Signatera™ Genome CC
Watch Video
-
MRD in a minute: Changing how cancer is managed
Watch Video
-
Loading More...
